Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...
Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.
Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...
Ovarian cancer is often diagnosed late because its symptoms resemble those of less serious conditions. As a result, only 20% ...
Watch the complete video to know the warning signs that the body may send when you are suffering from ovarian cancer. It ...
A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved ...
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...